# XERIS BIOPHARMA HOLDINGS, INC. (XERS) FY2026 YTD Q2 P&L / Income Statement

- Company: XERIS BIOPHARMA HOLDINGS, INC. (XERS)
- Period: 2026-01-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-06, accession number 0001867096-26-000065
- Page: https://plicit.ai/financials/xers/fy2026-ytd-q2-income-statement
- Chart image: https://plicit.ai/charts/xers-fy2026-ytd-q2-income-statement-sankey.png

## Chart details: Revenue by Product and Service (5 categories)

Income statement for 2026-01-01 through 2026-06-30. View: Product and service (5 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Product revenue, net**: 175,227,000 US dollars
- **Cost of revenue (calculated)**: 23,086,000 US dollars
- **Gross profit (calculated)**: 152,141,000 US dollars
- **Operating expenses (calculated)**: 139,052,000 US dollars
- **Income from operations**: 13,089,000 US dollars
- **Other income (expense), net (calculated)**: negative 41,956,000 US dollars
- **Net loss before income taxes**: negative 28,867,000 US dollars
- **Income tax benefit**: 0 US dollars
- **Net loss**: negative 28,867,000 US dollars
- **Royalty, contract and other revenue**: 1,769,000 US dollars
- **Recorlev**: 106,548,000 US dollars
- **Gvoke**: 43,349,000 US dollars
- **Keveyis**: 23,561,000 US dollars
- **Other product revenue**: 0 US dollars
- **Cost of goods sold**: 23,086,000 US dollars
- **Research and development**: 19,452,000 US dollars
- **Selling, general and administrative**: 114,179,000 US dollars
- **Amortization of intangible assets**: 5,421,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Product and Service (2 categories)

- Page: https://plicit.ai/financials/xers/fy2026-ytd-q2-income-statement/revenue-by-product-and-service-2-categories
- Chart image: https://plicit.ai/charts/xers-fy2026-ytd-q2-revenue-by-product-and-service-2-categories-sankey.png

Income statement for 2026-01-01 through 2026-06-30. View: Product and service (2 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Product revenue, net**: 175,227,000 US dollars
- **Cost of revenue (calculated)**: 23,086,000 US dollars
- **Gross profit (calculated)**: 152,141,000 US dollars
- **Operating expenses (calculated)**: 139,052,000 US dollars
- **Income from operations**: 13,089,000 US dollars
- **Other income (expense), net (calculated)**: negative 41,956,000 US dollars
- **Net loss before income taxes**: negative 28,867,000 US dollars
- **Income tax benefit**: 0 US dollars
- **Net loss**: negative 28,867,000 US dollars
- **Product revenue, net**: 173,458,000 US dollars
- **Royalty, contract and other revenue**: 1,769,000 US dollars
- **Cost of goods sold**: 23,086,000 US dollars
- **Research and development**: 19,452,000 US dollars
- **Selling, general and administrative**: 114,179,000 US dollars
- **Amortization of intangible assets**: 5,421,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.